Cleveland Clinic | 12th Annual Obesity Summit
Avatar

Management of Hypertension and Hyperlipidemia in Type 2 Diabetes

By Cleveland Clinic | 12th Annual Obesity Summit FEATURING Steven Nissen
December 3, 2017
2 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Cardiometabolic Health Congress (CMHC)

CMHC Masterclass: Addressing Cardiometabolic Risk in Children and Adoles...

Thu, Jan 28, 2021
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

16:57
William White

Ambulatory Blood Pressure Monitoring

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Aci...

Feat. R. Mason
18:25
ARCH Advanced Revascularization Symposium

Hypertension 2016: Guidelines and Updates

42:25
Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How To Tr...

Feat. A. Klein
28:22
Richard Auchus

Primary Aldosteronism and Implications for Primary Hypertension

13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

15:08
Cardiology Pulse 2019

Top 5 Cardiovascular Prevention Trials

Feat. R. Chilton
17:04
Cardiometabolic Health Congress (CMHC)

Part 2 - What Have We Learned from the CANTOS Trial and Looking Forward?

15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

Cleveland Clinic Heart, Vascular and Thoracic Institute

Effect of Left Ventricular Conduction Delay on Cardiovascular Mortality

Feat. D. Cantillon
29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Card...

28:09
ASPC 2019 Congress on CVD Prevention

LDL-C lowering and the Brain: Differentiating Fact from Fiction

Feat. P. Toth
09:38
George Bakris

Hyperkalemia in Chronic Kidney Disease

05:11
Venous Symposium

What Are the Factors Associated with the Increased Severity of Chronic V...

Feat. T. Urbanek
16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...

Feat. P. Moriarty
13:57
American Heart & Vascular Institute

Update on Lipid Management for ASCVD Prevention: What Is New in the Chol...

Feat. E. Brinton
18:43
Bonita Falkner

Recent Advances in Pediatric Hypertension

16:23
Cardiometabolic Health Congress (CMHC)

Part 1 - Targeting Inflammation- Updates on Pathophysiology and Clinical...

Feat. P. Libby